Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Schizophr Res. 2011 Nov 21;136(1-3):88–95. doi: 10.1016/j.schres.2011.10.013

Fig. 3.

Fig. 3

Effect of systemic administration of SR142948A on A) hyperlocomotion and B) rearing, induced by d-amphetamine and dizocilpine, or apomorphine. Pretreatment with SR142948A (100 μ/kg) had no effect on hyperlocomotion induced by d-amphetamine (2 mg/kg) and dizocilpine (0.1 mg/kg), or apomorphine (0.5 mg/kg). *p<0.05, **p<0.01 (D-amph: d-amphetamine; apo: apomorphine); n=7–12 in each group.